Epidemiology and treatment of epistaxis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021633

Enrollment

673

Registered

2020-05-04

Start date

2020-02-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R04.0

Interventions

Group 1: Data of patients with epistaxis who have been treated stationary will be analyzed independently of the treatment.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: stationary treatement, majority

Exclusion criteria

Exclusion criteria: episatxis as a postoperative complication or traumatic cause; ambulatory treatment, minority

Design outcomes

Primary

Measure	Time frame
What: Primary outcome is the treatment that each patient received. When: This parameter is taken retrospectively. How: Data extraction was performed from in-house-software.	—

Secondary

Measure	Time frame
localization of bleeding; risk factors; radiographic findings and corresponding pathologies; complications of epistaxis and treatment; stationary time.	—

Countries

Germany

Contacts

Public ContactTanja Hildenbrand

HNO-Uniklinik Freiburg

tanja.hildenbrand@uniklinik-freiburg.de0049 76127041970

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026